Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Oral human papillomavirus in healthy individuals: a systematic review of the literature.

Kreimer AR, Bhatia RK, Messeguer AL, González P, Herrero R, Giuliano AR.

Sex Transm Dis. 2010 Jun;37(6):386-91. doi: 10.1097/OLQ.0b013e3181c94a3b. Review.

PMID:
20081557
2.
3.

Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium.

Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan'gina O, Schwartz SM, Purdue MP, Pilarska A, Eluf-Neto J, Menezes A, McClean MD, Matos E, Koifman S, Kelsey KT, Herrero R, Hayes RB, Franceschi S, Wünsch-Filho V, Fernández L, Daudt AW, Curado MP, Chen C, Castellsagué X, Ferro G, Brennan P, Boffetta P, Hashibe M.

Int J Epidemiol. 2010 Feb;39(1):166-81. doi: 10.1093/ije/dyp350.

4.

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.

Olsson SE, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Hum Vaccin. 2009 Oct;5(10):696-704.

PMID:
19855170
5.

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.

Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Lu S, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Cancer Prev Res (Phila). 2009 Oct;2(10):868-78. doi: 10.1158/1940-6207.CAPR-09-0031.

6.

Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.

Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER.

J Infect Dis. 2009 Oct 1;200(7):1059-67. doi: 10.1086/604729.

7.

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data.

Sasieni P, Castanon A, Cuzick J.

BMJ. 2009 Jul 28;339:b2968. doi: 10.1136/bmj.b2968. Erratum in: BMJ. 2009;339:b3115.

8.

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group..

Lancet. 2009 Jul 25;374(9686):301-14. doi: 10.1016/S0140-6736(09)61248-4. Erratum in: Lancet. 2010 Sep 25;376(9746):1054.

PMID:
19586656
10.

Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia.

Park IU, Ogilvie JW Jr, Anderson KE, Li ZZ, Darrah L, Madoff R, Downs L Jr.

Gynecol Oncol. 2009 Sep;114(3):399-403. doi: 10.1016/j.ygyno.2009.05.008.

PMID:
19501896
11.

The epidemiology of anal human papillomavirus and related neoplasia.

Palefsky JM, Rubin M.

Obstet Gynecol Clin North Am. 2009 Mar;36(1):187-200. doi: 10.1016/j.ogc.2009.02.003. Review.

PMID:
19344856
12.

Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies.

International Collaboration of Epidemiological Studies of Cervical Cancer..

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1060-9. doi: 10.1158/1055-9965.EPI-08-1186.

13.

Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity.

Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A.

Cancer Causes Control. 2009 Sep;20(7):1129-38. doi: 10.1007/s10552-009-9317-z.

PMID:
19253025
14.

Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study.

de Pokomandy A, Rouleau D, Ghattas G, Vézina S, Coté P, Macleod J, Allaire G, Franco EL, Coutlée F; HIPVIRG Study Group..

J Infect Dis. 2009 Apr 1;199(7):965-73. doi: 10.1086/597207.

15.

Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study.

Shvetsov YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu X, Ning L, Killeen J, Kamemoto L, Goodman MT.

Clin Infect Dis. 2009 Mar 1;48(5):536-46. doi: 10.1086/596758.

16.

Factors that influence the rate of epithelial maturation in the cervix in healthy young women.

Hwang LY, Ma Y, Benningfield SM, Clayton L, Hanson EN, Jay J, Jonte J, Godwin de Medina C, Moscicki AB.

J Adolesc Health. 2009 Feb;44(2):103-10. doi: 10.1016/j.jadohealth.2008.10.006.

17.

Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2.

Castle PE, Schiffman M, Wheeler CM, Solomon D.

Obstet Gynecol. 2009 Jan;113(1):18-25. doi: 10.1097/AOG.0b013e31818f5008.

18.

Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology.

Moscicki AB, Ma Y, Wibbelsman C, Powers A, Darragh TM, Farhat S, Shaber R, Shiboski S.

Obstet Gynecol. 2008 Dec;112(6):1335-42. doi: 10.1097/AOG.0b013e31818c9222.

19.

Interaction of human papillomaviruses with the host immune system: a well evolved relationship.

Frazer IH.

Virology. 2009 Feb 20;384(2):410-4. doi: 10.1016/j.virol.2008.10.004. Review.

20.

Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.

Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, Richards TB.

Cancer. 2008 Nov 15;113(10 Suppl):2841-54. doi: 10.1002/cncr.23758.

Items per page

Supplemental Content

Support Center